Fort LP’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,517
Closed -$746K 295
2021
Q2
$746K Buy
4,517
+2,582
+133% +$431K 0.22% 200
2021
Q1
$297K Buy
+1,935
New +$263K 0.08% 233
2020
Q2
Sell
-504
Closed -$42K 350
2020
Q1
$42K Sell
504
-147
-23% -$14.3K 0.01% 345
2019
Q4
$72K Sell
651
-4,760
-88% -$490K 0.01% 382
2019
Q3
$537K Sell
5,411
-5,349
-50% -$531K 0.1% 244
2019
Q2
$1.07M Buy
10,760
+1,317
+14% +$126K 0.2% 190
2019
Q1
$1.04M Buy
9,443
+482
+5% +$50.4K 0.21% 191
2018
Q4
$824K Buy
8,961
+3,267
+57% +$331K 0.19% 190
2018
Q3
$627K Buy
+5,694
New +$593K 0.14% 199

Other funds holding PRAH

Fort LP's PRAH Position: Q3 2021 in Review

Fort LP sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 4,517 shares — an estimated $746K sold.

Fort LP first reported a position in PRAH in Q3 2018 and held it in 9 quarters. The position peaked at $1.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Fort LP reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Fort LP sold 4,517 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $746K.
  • Fort LP first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 9 quarters.
  • Fort LP's PRA Health Sciences, Inc. position peaked at $1.07M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Fort LP's 13F filing for Q3 2021, filed 12 Nov 2021.